1 report

IN ADDITION, INTAS IS ALSO THE ONLY COMPANY FROM INDIA TO HAVE TWO OF ITS BIOSIMILARS, FILGRASTIM AND PEG-FILGRASTIM FILED FOR REGISTRATION IN THE US.

  • Catheter
  • North America
  • United States
  • Forecast
  • Market Size